Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecular profiling of postmenopausal women with breast cancer on neoadjuvant exemestane or tamoxifen
2005-001698-89Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of exemestane and tamoxifen in breast cancer (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Molecular markers predictive of response or resistance. Started May 2006; status: completed.
02
Drugs
exemestanetamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-001698-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001698-89.